Cargando…

Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma

The prognosis of adult T-cell leukemia-lymphoma (ATL) remains very poor, and there is an urgent clinical need to investigate novel therapies for ATL. The expression of phosphatidylinositol 3-kinase-δ (PI3k-δ) is normally restricted to hematopoietic cells and is known as a key determinant of cell sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katsuya, Hiroo, Cook, Lucy B. M., Rowan, Aileen G., Satou, Yorifumi, Taylor, Graham P., Bangham, Charles R. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052569/ https://www.ncbi.nlm.nih.gov/pubmed/30034808 http://dx.doi.org/10.1186/s40364-018-0138-7

Ejemplares similares

Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome
por: Cohen, Jeffrey I.
Publicado: (2018)

Phosphatidylinositol 3-Kinase (PI3K) δ blockade increases genomic instability in B cells
por: Compagno, Mara, et al.
Publicado: (2017)

Phosphatidylinositol 3‐Kinase δ Deficiency Protects From Antimyeloperoxidase Vasculitis
por: Flórez‐Barrós, Fernanda, et al.
Publicado: (2022)

Identification of long-range chromatin interactions between HTLV-1 and the host genome
por: Yaguchi, Hiroko, et al.
Publicado: (2015)

Phosphatidylinositol 3-kinase p110δ expression in Merkel cell carcinoma
por: Chteinberg, Emil, et al.
Publicado: (2018)

Absorption, Distribution, and Binding Profile of ME-401, a Potent and Selective Oral Small-Molecule Inhibitor of Phosphatidylinositol 3-Kinase δ (PI3Kδ) in Animal and B-Cell Lymphoma Models
por: Moreno, Ofir, et al.
Publicado: (2019)

Puquitinib mesylate, an inhibitor of phosphatidylinositol 3-kinase p110δ, for treating relapsed or refractory non-Hodgkin's lymphoma
por: Yang, Hang, et al.
Publicado: (2015)

A Review of Phosphocreatine 3 Kinase δ Subtype (PI3Kδ) and Its Inhibitors in Malignancy
por: Xiang, Qiong, et al.
Publicado: (2021)

Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita
por: Koga, Hiroshi, et al.
Publicado: (2018)

Regulation of p110δ PI 3-Kinase Gene Expression
por: Kok, Klaartje, et al.
Publicado: (2009)

Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib
por: Till, Kathleen J., et al.
Publicado: (2023)

A Crucial Role for the p110δ Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and Activation
por: Clayton, Elizabeth, et al.
Publicado: (2002)

PI3Kδ Inhibitors as Immunomodulatory Agents for the Treatment of Lymphoma Patients
por: Tarantelli, Chiara, et al.
Publicado: (2021)

p110δ PI3 kinase pathway: emerging roles in cancer
por: Tzenaki, Niki, et al.
Publicado: (2013)

Phosphatidylinositol 3‐kinase‐δ controls endoplasmic reticulum membrane fluidity and permeability in fungus‐induced allergic inflammation in mice
por: Lee, Hwa‐Young, et al.
Publicado: (2020)

Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?
por: Rowan, Aileen G., et al.
Publicado: (2012)

Enhanced Cell Killing by Overexpression of Dominant‐negative Phosphatidylinositol 3‐Kinase Subunit, Δp85, Following Genotoxic Stresses
por: Tachiiri, Seiji, et al.
Publicado: (2000)

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome
por: Rao, V. Koneti, et al.
Publicado: (2023)

Hyper-activated PI3K-δ in immunodeficiency
por: Heurtier, Lucie, et al.
Publicado: (2015)

The Treatment of Activated PI3Kδ Syndrome
por: Coulter, Tanya I., et al.
Publicado: (2018)

Discovery of Novel PI3Kδ Inhibitors Based on the p110δ Crystal Structure
por: Jia, Wenqing, et al.
Publicado: (2022)

Occurrence of B-cell lymphomas in patients with Activated Phosphoinositide 3-Kinase δ syndrome
por: Kracker, Sven, et al.
Publicado: (2014)

Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus
por: Miyazato, Paola, et al.
Publicado: (2016)

PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors
por: Yahiaoui, Anella, et al.
Publicado: (2017)

The PI3K p110δ Regulates Expression of CD38 on Regulatory T Cells
por: Patton, Daniel T., et al.
Publicado: (2011)

Control of Axonal Growth and Regeneration of Sensory Neurons by the p110δ PI 3-Kinase
por: Eickholt, Britta J., et al.
Publicado: (2007)

ANCA vasculitis expands the spectrum of autoimmune manifestations of activated PI3 kinase δ syndrome
por: Sood, Amika K., et al.
Publicado: (2023)

Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ
por: Uehara, Mayuko, et al.
Publicado: (2017)

Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
por: Akinleye, Akintunde, et al.
Publicado: (2013)

PI3Kδ is indispensable for CTL-mediated cytotoxicity
por: Putz, Eva M, et al.
Publicado: (2011)

Case Report: First Occurrence of Plasmablastic Lymphoma in Activated Phosphoinositide 3-Kinase δ Syndrome
por: Yin, Zexi, et al.
Publicado: (2021)

Molecular characterization of heterogeneity in adult T-cell leukaemia/lymphoma
por: Kagdi, Huseini, et al.
Publicado: (2015)

Molecular characterization of heterogeneity in adult T-cell leukaemia/lymphoma
por: Kagdi, Huseini, et al.
Publicado: (2015)

Simultaneous targeting of PI3Kδ and a PI3Kδ-dependent MEK1/2-Erk1/2 pathway for therapy in pediatric B-cell acute lymphoblastic leukemia
por: Wang, Xiang, et al.
Publicado: (2014)

HTLV-1 inserts an ectopic CTCF-binding site into the human genome
por: Satou, Yorifumi, et al.
Publicado: (2015)

Disorders Related to PI3Kδ Hyperactivation: Characterizing the Clinical and Immunological Features of Activated PI3-Kinase Delta Syndromes
por: Redenbaugh, Vyanka, et al.
Publicado: (2021)

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
por: Knowles, Margaret A., et al.
Publicado: (2009)

T Cell Receptor Vβ Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8(+) T cells
por: Rowan, Aileen G., et al.
Publicado: (2016)

CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application
por: Winkler, B. Sophia, et al.
Publicado: (2015)

PI3Kδ过度活化综合征一例
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9emr4o8s0879edgl44m32o9atq